The purpose of this study was to develop a multi-site near-infrared (NIR) model (Model I) and compare its predictive accuracy to single-site models (IIA and IIB). In Model I, the sum of two optical density (OD) measures (Σ2OD), age, body weight, height, and physical activity level were used as potential predictors of body density (D ). In Model IIA, the variables used in the manufacturer's NIR equation (biceps OD and OD , body weight, height, gender, and physical activity level) were the potential predictors. This model was modified by including age as an additional potential predictor in Model IIB. We also examined the test-retest reliability and interrelationships of OD measures taken at 10 anatomical sites, as well as the validity of the manufacturer's NIR equation, for estimating body composition of women. The subjects, 148 women between 20 and 72 years, were hydrostatically weighed to determine criterion D . The Futrex-5000 was used to measure OD and OD at 10 anatomical sites. Only two sites (pectoral OD and biceps OD ) contributed significantly to the variance in D . Thus, the sum of these two ODs (Σ2OD), was used as a potential predictor in the multi-site model. Test-retest reliability was high, with intraclass correlation coefficients ≥0.85 for many of the OD measurements. Intercorrelations of ODs ranged from 0.22 to 0.91. In the multi-site model (I), ΣOD, body weight, age, and height were significant predictors, accounting for 85.7% of the variance in D . The SEE was 0.0076 g/ml or 3.3% BF. In the manufacturer's model (IIA), biceps OD , body weight, and height accounted for 76.3% of the variance in D , and the SEE was 0.0094 g/ml (4.1% BF). When age was included as a predictor (Model IIB), the R increased (86.0%) and the SEE (0.0073 g/ml or 3.1% BF) decreased substantially. Cross-validation of the three equations yielded r s ranging between 0.688 (Model IIA) and 0.748 (Model I) and slightly larger SEEs (0.0094-0.001048 g/ml). There were no significant differences between average criterion D and predicted D for each equation. The manufacturer's equation programmed in the Futrex-5000 yielded a lower r (0.55), higher SEE (5.61% BF), and significantly underestimated criterion % BF by an average of 3% BF. Either the multi-site (model I) or single-site (Model IIB) equations is recommended to estimate body composition of this population. © 1992 Wiley-Liss, Inc.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ajhb.1310040504 | DOI Listing |
Lipids Health Dis
January 2025
Department of Basic Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.
Background: Obesity can arise from various physiological disorders. This research examined the impacts of the bacteriocin, gassericin A, which is generated by certain gut bacteria, using an in vivo model of obesity.
Methods: Fifty Swiss NIH mice were randomly assigned to five different groups.
BMC Nephrol
January 2025
Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Background: The prevalence of chronic kidney disease (CKD) is estimated to be about 13.4% worldwide. Studies have shown that CKD accounts for up to 2% of the health cost burden.
View Article and Find Full Text PDFNat Med
January 2025
Data Science, Novo Nordisk A/S, Søborg, Denmark.
Obesity and type 2 diabetes are prevalent chronic diseases effectively managed by semaglutide. Here we studied the effects of semaglutide on the circulating proteome using baseline and end-of-treatment serum samples from two phase 3 trials in participants with overweight or obesity, with or without diabetes: STEP 1 (n = 1,311) and STEP 2 (n = 645). We identified evidence supporting broad effects of semaglutide, implicating processes related to body weight regulation, glycemic control, lipid metabolism and inflammatory pathways.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea.
Colon cancer is a significant health concern, and obesity is a well-established risk factor. However, previous studies have mainly focused on assessing body weight as a risk factor for colon cancer at a specific time point. This nationwide cohort study investigated the association between body weight changes, which can fluctuate throughout an individual's lifespan, and the incidence of colon cancer using the South Korean population database provided by the National Health Insurance Service (NHIS).
View Article and Find Full Text PDFIntroduction: Pediatric patients are more likely to experience medication-related errors and serious associated harms. The identification of high-risk medications (HRM) and their study in special populations, such as children with excess body weight (EBW), is a part of safety improvement strategies.
Objective: To generate, through a consensus technique structured by an interdisciplinary group of pediatricians and hospital pharmacists, an operational and updated list of HRM for hospital use in children over 2 years of age.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!